Melanoma cells present high levels of HLA-A2-tyrosinase in association with instability and aberrant intracellular processing of tyrosinase. Michaeli Y, Sinik K, Haus-Cohen M, Reiter Y, Eur J Immunol. 2012 Apr;42(4):842-50.
T-cell-receptor-like antibodies – generation, function and applications. Dahan R, Reiter Y, Expert Rev Mol Med. 2012 Feb 24;14:e6.
Electrically controlled molecular recognition harnessed to activate a cellular response. Artzy-Schnirman A, Blat D, Talmon Y, Fishler R, Gertman D, Oren R, Wolchinsky R, Waks T, Benhar I, Eshhar Z, Sivan U, Reiter Y. Nano Lett. 2011 Nov 9;11(11):4997-5001.
TCR-like antibodies distinguish conformational and functional differences in two- versus four-domain auto reactive MHC class II-peptide complexes. Dahan R, Tabul M, Chou YK, Meza-Romero R, Andrew S, Ferro AJ, Burrows GG, Offner H, Vandenbark AA, Reiter Y. Eur J Immunol. 2011 May;41(5):1465-79.
Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR. Klechevsky E, Flamar AL, Cao Y, Blanck JP, Liu M, O’Bar A, Agouna-Deciat O, Klucar P, Thompson-Snipes L, Zurawski S, Reiter Y, Palucka AK, Zurawski G, Banchereau J. Blood. 2010 Sep 9;116(10):1685-97
Direct visualization of the dynamics of antigen presentation in human cells infected with cytomegalovirus revealed by antibodies mimicking TCR specificity. Makler O, Oved K, Netzer N, Wolf D, Reiter Y. Eur J Immunol. 2010 Jun;40(6):1552-65.
Expression hierarchy of T cell epitopes from melanoma differentiation antigens: unexpected high level presentation of tyrosinase-HLA-A2 Complexes revealed by peptide-specific, MHC-restricted, TCR-like antibodies. Michaeli Y, Denkberg G, Sinik K, Lantzy L, Chih-Sheng C, Beauverd C, Ziv T, Romero P, Reiter Y.
Predicting and controlling the reactivity of immune cell populations against cancer. Oved K, Eden E, Akerman M, Noy R, Wolchinsky R, Izhaki O, Schallmach E, Kubi A, Zabari N, Schachter J, Alon U, Mandel-Gutfreund Y, Besser MJ, Reiter Y. Mol Syst Biol. 2009;5:265. Epub 2009 Apr 28. J Immunol. 2009 May 15;182(10):6328-41.
Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells. Klechevsky E, Morita R, Liu M, Cao Y, Coquery S, Thompson-Snipes L, Briere F, Chaussabel D, Zurawski G, Palucka AK, Reiter Y, Banchereau J, Ueno H. Immunity. 2008 Sep 19;29(3):497-510.
Antitumor activity of immunotoxins with T-cell receptor-like specificity against human melanoma xenografts. Klechevsky E, Gallegos M, Denkberg G, Palucka K, Banchereau J, Cohen C, Reiter Y. Cancer Res. 2008 Aug 1;68(15):6360-7.
Phage display-derived recombinant antibodies with TCR-like specificity against alpha-galactosylceramide and its analogues in complex with human CD1d molecules. Denkberg G, Stronge VS, Zahavi E, Pittoni P, Oren R, Shepherd D, Salio M, McCarthy C, Illarionov PA, van der Merwe A, Besra GS, Dellabona P, Casorati G, Cerundolo V, Reiter Y. Eur J Immunol. 2008 Mar;38(3):829-40.
Novel antibodies as anticancer agents. Zafir-Lavie I, Michaeli Y, Reiter Y. Oncogene. 2007 May 28;26(25):3714-33. Review.
A novel postpriming regulatory check point of effector/memory T cells dictated through antigen density threshold-dependent anergy. Oved K, Ziv O, Jacob-Hirsch J, Noy R, Novak H, Makler O, Galit D, Keren S, Segal D, Gefen-Dor C, Amariglio N, Rechavi G, Reiter Y. J Immunol. 2007 Feb 15;178(4):2307-17.